User login
The Advisory Council on Immunization Practices (ACIP) reports that the only contraindication for all vaccines is a history of severe allergic reaction to a previous vaccine or vaccine constituent (strength of recommendations: C, based predominantly on case series, case reports, and expert opinion).
Vaccination is safe and efficacious in the following situations: during a mild illness (eg, diarrhea, otitis media or other mild upper respiratory infection whether or not the patient has a fever), during antimicrobial therapy, during the convalescent phase of an acute illness, when breastfeeding, and after mild to moderate reactions to a previous dose of vaccine.
Live vaccines (varicella, MMR) should not be used for pregnant women or significantly immunocompromised patients, and may not be effective for patients receiving immunoglobulin therapy. They can be administered to HIV-positive patients who are asymptomatic or not severely immunosuppressed, as determined by age-specific CD4 counts.
Evidence summary
Public misperceptions and provider uncertainty about contraindications create missed opportunities for immunization.1-3 The Centers for Disease Control and Prevention (CDC) defines contraindications as conditions that increase the risk of a serious reaction to vaccination. Precautions are conditions that might increase the risk of a serious reaction, or that diminish vaccine efficiency.4 Recommendations about contraindications and precautions for vaccine administration are partially based on studies of adverse effects (see the TABLE for common situations). Complete information on the contraindications and precautions for all common vaccinations can be accessed at www.cdc.gov/mmwr/preview/mmwrhtml/rr5102a1.htm#tab5.4
Data on vaccination risks are limited by a relative lack of experimental studies. Initial recommendations of the Advisory Council on Immunization Practices have been based on the findings of a 14-member Institute of Medicine (IOM) expert committee and are updated regularly.5-7 The IOM committee reported that because vaccine-related adverse events occur infrequently, available randomized controlled trials were too small to detect differences in incidence.6 Much of the data come from adverse effect surveillance systems, such as the Vaccine Adverse Event Reporting System (VAERS), to which health care providers report possible adverse effects of vaccinations.
Updated contraindications by ACIP to the initial IOM recommendations have also been based on observational reports and studies.4 A recent Cochrane review on acellular pertussis vaccines concluded that the acellular vaccine had fewer adverse effects than the whole-cell version, but did not support any changes in contraindications or precautions.8
TABLE
Contraindications and precautions for vaccine administration
| SITUATION | COMMENTS |
|---|---|
| Mild acute illness (with or without fever) (otitis media, diarrhea, etc) | No contraindication |
| Breastfeeding | No contraindication |
| Serious allergic reaction to vaccine or component (anaphylaxis) | Absolute contraindication |
| Pregnancy | Tetanus and influenza should be kept current |
| No contraindication to give indicated inactivated immunizations | |
| Live vaccines are contraindicated, although no reports of adverse reactions reported | |
| Moderate to severe illness | Temporary precaution—hold until patient improved |
| Encephalopathy <1 week after DTP or DtaP | Pertussis immunization contraindicated |
| Fever >40.5° C or Hypotonic, hyporesponsive episode or Persistent, inconsolable crying >3 hours <48 hours after DTP or DTaP or seizure <3 days after DTP or DTaP | Avoid pertussis, but vaccination may be appropriate during an outbreak |
| Recipients of blood, IVIG, and other antibody-containing products | Hold live vaccines for variable timing depending on dose (see CDC Recommendations) |
| Oral typhoid and yellow fever OK | |
| Chemotherapy or radiotherapy | Give influenza |
| Avoid others (decreased immune response) | |
| Antibacterials | Should not be taken with oral (live) typhoid vaccine (decreased effectiveness) |
| Antivirals against herpes spp | Should not be taken with live varicella vaccine (decreased effectiveness) |
| Postpartum anti-Rho(D) | Simultaneous rubella vaccination effective |
| Hematopoietic Stem Cell transplant recipients | See separate CDC Recommendations* |
| Altered immune status (HIV, solid organ transplant recipients, etc) | See separate CDC Recommendations† |
| Inactivated immunizations are safe, may be less effective | |
| Table based on general recommendations on immunization, MMWR Recomm Rep 2002.4 | |
| *Available at: www.cdc.gov/mmwr/preview/mmwrhtml/rr4910a1.htm | |
| † For HIV, www.cdc.gov/mmwr/preview/mmwrhtml/rr5108a1.htm; for others, www.cdc.gov/mmwr/preview/mmwrhtml/00023141.htm. | |
Recommendations from others
The ACIP recommendations serve as national standards and have been adopted by American Academy of Pediatrics and the American Academy of Family Physicians and are included in most standard reference texts.4,9
Know true contraindications; provide clear, factual information to concerned parents
Rebecca Meriwether, MD
Tulane University, New Orleans, La
Immunizations are among the safest and most cost-effective interventions available in modern medicine. Offices should be organized to assist in assuring delivery of immunizations during preventive, sick, and follow-up visits, and to follow recommended and catch-up schedules to reduce the time patients are susceptible to preventable infectious diseases. Failure to vaccinate due to inappropriate contraindications, particularly mild illness, is a missed opportunity and significant contributor to under-immunization. Know and observe true contraindications and provide clear, factual information to parents concerned about vaccine risks. When temporarily delaying vaccination is prudent—eg, with evolving neurologic conditions and moderate to severe illness—scheduling a return visit for immunizations and documenting the intention to vaccinate at the next visit are strategies to reduce the risk that catch-up immunization will be forgotten.
1. Wald ER, Dashefsky B, Byers C, Guerra N, Taylor F. Frequency and severity of infections in day care. J Pediatr 1988;112:540-546.
2. Szilagyi PG, Rodewald LE. Missed opportunities for immunizations: a review of the evidence. J Public Health Manag Pract 1996;2:18-25.
3. Farizo KM, Stehr-Green PA, Markowitz LE, Patriarca PA. Vaccination levels and missed opportunities for measles vaccination: a record audit in a public pediatric clinic. Pediatrics 1992;89:589-592.
4. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices and the American Academy of Family Physicians. MMWR Recomm Rep 2002;51(RR-2):1-35.
5. Howson CP, Howe CJ, Fineberg HV, eds. Adverse Effects of Pertussis and Rubella Vaccines. Washington, DC: National Academy Press, last updated 1991. Available at: www.nap.edu/books/0309044995/html/index.html. Accessed on June 10, 2005.
6. Stratton KR, Howe CJ, Johnston RB, eds. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: National Academy Press, Last updated 1994. Available at: www.nap.edu/catalog/2138.html. Accessed on June 10, 2005.
7. Update: vaccine side effects, adverse reactions, contraindications, and precautions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996;45(RR-12):1-35.
8. Tinnion ON, Hanlon M. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2000(2);CD001478.-
9. American Academy of Pediatrics. Active and Passive Immunization. In: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2003;46-49.
The Advisory Council on Immunization Practices (ACIP) reports that the only contraindication for all vaccines is a history of severe allergic reaction to a previous vaccine or vaccine constituent (strength of recommendations: C, based predominantly on case series, case reports, and expert opinion).
Vaccination is safe and efficacious in the following situations: during a mild illness (eg, diarrhea, otitis media or other mild upper respiratory infection whether or not the patient has a fever), during antimicrobial therapy, during the convalescent phase of an acute illness, when breastfeeding, and after mild to moderate reactions to a previous dose of vaccine.
Live vaccines (varicella, MMR) should not be used for pregnant women or significantly immunocompromised patients, and may not be effective for patients receiving immunoglobulin therapy. They can be administered to HIV-positive patients who are asymptomatic or not severely immunosuppressed, as determined by age-specific CD4 counts.
Evidence summary
Public misperceptions and provider uncertainty about contraindications create missed opportunities for immunization.1-3 The Centers for Disease Control and Prevention (CDC) defines contraindications as conditions that increase the risk of a serious reaction to vaccination. Precautions are conditions that might increase the risk of a serious reaction, or that diminish vaccine efficiency.4 Recommendations about contraindications and precautions for vaccine administration are partially based on studies of adverse effects (see the TABLE for common situations). Complete information on the contraindications and precautions for all common vaccinations can be accessed at www.cdc.gov/mmwr/preview/mmwrhtml/rr5102a1.htm#tab5.4
Data on vaccination risks are limited by a relative lack of experimental studies. Initial recommendations of the Advisory Council on Immunization Practices have been based on the findings of a 14-member Institute of Medicine (IOM) expert committee and are updated regularly.5-7 The IOM committee reported that because vaccine-related adverse events occur infrequently, available randomized controlled trials were too small to detect differences in incidence.6 Much of the data come from adverse effect surveillance systems, such as the Vaccine Adverse Event Reporting System (VAERS), to which health care providers report possible adverse effects of vaccinations.
Updated contraindications by ACIP to the initial IOM recommendations have also been based on observational reports and studies.4 A recent Cochrane review on acellular pertussis vaccines concluded that the acellular vaccine had fewer adverse effects than the whole-cell version, but did not support any changes in contraindications or precautions.8
TABLE
Contraindications and precautions for vaccine administration
| SITUATION | COMMENTS |
|---|---|
| Mild acute illness (with or without fever) (otitis media, diarrhea, etc) | No contraindication |
| Breastfeeding | No contraindication |
| Serious allergic reaction to vaccine or component (anaphylaxis) | Absolute contraindication |
| Pregnancy | Tetanus and influenza should be kept current |
| No contraindication to give indicated inactivated immunizations | |
| Live vaccines are contraindicated, although no reports of adverse reactions reported | |
| Moderate to severe illness | Temporary precaution—hold until patient improved |
| Encephalopathy <1 week after DTP or DtaP | Pertussis immunization contraindicated |
| Fever >40.5° C or Hypotonic, hyporesponsive episode or Persistent, inconsolable crying >3 hours <48 hours after DTP or DTaP or seizure <3 days after DTP or DTaP | Avoid pertussis, but vaccination may be appropriate during an outbreak |
| Recipients of blood, IVIG, and other antibody-containing products | Hold live vaccines for variable timing depending on dose (see CDC Recommendations) |
| Oral typhoid and yellow fever OK | |
| Chemotherapy or radiotherapy | Give influenza |
| Avoid others (decreased immune response) | |
| Antibacterials | Should not be taken with oral (live) typhoid vaccine (decreased effectiveness) |
| Antivirals against herpes spp | Should not be taken with live varicella vaccine (decreased effectiveness) |
| Postpartum anti-Rho(D) | Simultaneous rubella vaccination effective |
| Hematopoietic Stem Cell transplant recipients | See separate CDC Recommendations* |
| Altered immune status (HIV, solid organ transplant recipients, etc) | See separate CDC Recommendations† |
| Inactivated immunizations are safe, may be less effective | |
| Table based on general recommendations on immunization, MMWR Recomm Rep 2002.4 | |
| *Available at: www.cdc.gov/mmwr/preview/mmwrhtml/rr4910a1.htm | |
| † For HIV, www.cdc.gov/mmwr/preview/mmwrhtml/rr5108a1.htm; for others, www.cdc.gov/mmwr/preview/mmwrhtml/00023141.htm. | |
Recommendations from others
The ACIP recommendations serve as national standards and have been adopted by American Academy of Pediatrics and the American Academy of Family Physicians and are included in most standard reference texts.4,9
Know true contraindications; provide clear, factual information to concerned parents
Rebecca Meriwether, MD
Tulane University, New Orleans, La
Immunizations are among the safest and most cost-effective interventions available in modern medicine. Offices should be organized to assist in assuring delivery of immunizations during preventive, sick, and follow-up visits, and to follow recommended and catch-up schedules to reduce the time patients are susceptible to preventable infectious diseases. Failure to vaccinate due to inappropriate contraindications, particularly mild illness, is a missed opportunity and significant contributor to under-immunization. Know and observe true contraindications and provide clear, factual information to parents concerned about vaccine risks. When temporarily delaying vaccination is prudent—eg, with evolving neurologic conditions and moderate to severe illness—scheduling a return visit for immunizations and documenting the intention to vaccinate at the next visit are strategies to reduce the risk that catch-up immunization will be forgotten.
The Advisory Council on Immunization Practices (ACIP) reports that the only contraindication for all vaccines is a history of severe allergic reaction to a previous vaccine or vaccine constituent (strength of recommendations: C, based predominantly on case series, case reports, and expert opinion).
Vaccination is safe and efficacious in the following situations: during a mild illness (eg, diarrhea, otitis media or other mild upper respiratory infection whether or not the patient has a fever), during antimicrobial therapy, during the convalescent phase of an acute illness, when breastfeeding, and after mild to moderate reactions to a previous dose of vaccine.
Live vaccines (varicella, MMR) should not be used for pregnant women or significantly immunocompromised patients, and may not be effective for patients receiving immunoglobulin therapy. They can be administered to HIV-positive patients who are asymptomatic or not severely immunosuppressed, as determined by age-specific CD4 counts.
Evidence summary
Public misperceptions and provider uncertainty about contraindications create missed opportunities for immunization.1-3 The Centers for Disease Control and Prevention (CDC) defines contraindications as conditions that increase the risk of a serious reaction to vaccination. Precautions are conditions that might increase the risk of a serious reaction, or that diminish vaccine efficiency.4 Recommendations about contraindications and precautions for vaccine administration are partially based on studies of adverse effects (see the TABLE for common situations). Complete information on the contraindications and precautions for all common vaccinations can be accessed at www.cdc.gov/mmwr/preview/mmwrhtml/rr5102a1.htm#tab5.4
Data on vaccination risks are limited by a relative lack of experimental studies. Initial recommendations of the Advisory Council on Immunization Practices have been based on the findings of a 14-member Institute of Medicine (IOM) expert committee and are updated regularly.5-7 The IOM committee reported that because vaccine-related adverse events occur infrequently, available randomized controlled trials were too small to detect differences in incidence.6 Much of the data come from adverse effect surveillance systems, such as the Vaccine Adverse Event Reporting System (VAERS), to which health care providers report possible adverse effects of vaccinations.
Updated contraindications by ACIP to the initial IOM recommendations have also been based on observational reports and studies.4 A recent Cochrane review on acellular pertussis vaccines concluded that the acellular vaccine had fewer adverse effects than the whole-cell version, but did not support any changes in contraindications or precautions.8
TABLE
Contraindications and precautions for vaccine administration
| SITUATION | COMMENTS |
|---|---|
| Mild acute illness (with or without fever) (otitis media, diarrhea, etc) | No contraindication |
| Breastfeeding | No contraindication |
| Serious allergic reaction to vaccine or component (anaphylaxis) | Absolute contraindication |
| Pregnancy | Tetanus and influenza should be kept current |
| No contraindication to give indicated inactivated immunizations | |
| Live vaccines are contraindicated, although no reports of adverse reactions reported | |
| Moderate to severe illness | Temporary precaution—hold until patient improved |
| Encephalopathy <1 week after DTP or DtaP | Pertussis immunization contraindicated |
| Fever >40.5° C or Hypotonic, hyporesponsive episode or Persistent, inconsolable crying >3 hours <48 hours after DTP or DTaP or seizure <3 days after DTP or DTaP | Avoid pertussis, but vaccination may be appropriate during an outbreak |
| Recipients of blood, IVIG, and other antibody-containing products | Hold live vaccines for variable timing depending on dose (see CDC Recommendations) |
| Oral typhoid and yellow fever OK | |
| Chemotherapy or radiotherapy | Give influenza |
| Avoid others (decreased immune response) | |
| Antibacterials | Should not be taken with oral (live) typhoid vaccine (decreased effectiveness) |
| Antivirals against herpes spp | Should not be taken with live varicella vaccine (decreased effectiveness) |
| Postpartum anti-Rho(D) | Simultaneous rubella vaccination effective |
| Hematopoietic Stem Cell transplant recipients | See separate CDC Recommendations* |
| Altered immune status (HIV, solid organ transplant recipients, etc) | See separate CDC Recommendations† |
| Inactivated immunizations are safe, may be less effective | |
| Table based on general recommendations on immunization, MMWR Recomm Rep 2002.4 | |
| *Available at: www.cdc.gov/mmwr/preview/mmwrhtml/rr4910a1.htm | |
| † For HIV, www.cdc.gov/mmwr/preview/mmwrhtml/rr5108a1.htm; for others, www.cdc.gov/mmwr/preview/mmwrhtml/00023141.htm. | |
Recommendations from others
The ACIP recommendations serve as national standards and have been adopted by American Academy of Pediatrics and the American Academy of Family Physicians and are included in most standard reference texts.4,9
Know true contraindications; provide clear, factual information to concerned parents
Rebecca Meriwether, MD
Tulane University, New Orleans, La
Immunizations are among the safest and most cost-effective interventions available in modern medicine. Offices should be organized to assist in assuring delivery of immunizations during preventive, sick, and follow-up visits, and to follow recommended and catch-up schedules to reduce the time patients are susceptible to preventable infectious diseases. Failure to vaccinate due to inappropriate contraindications, particularly mild illness, is a missed opportunity and significant contributor to under-immunization. Know and observe true contraindications and provide clear, factual information to parents concerned about vaccine risks. When temporarily delaying vaccination is prudent—eg, with evolving neurologic conditions and moderate to severe illness—scheduling a return visit for immunizations and documenting the intention to vaccinate at the next visit are strategies to reduce the risk that catch-up immunization will be forgotten.
1. Wald ER, Dashefsky B, Byers C, Guerra N, Taylor F. Frequency and severity of infections in day care. J Pediatr 1988;112:540-546.
2. Szilagyi PG, Rodewald LE. Missed opportunities for immunizations: a review of the evidence. J Public Health Manag Pract 1996;2:18-25.
3. Farizo KM, Stehr-Green PA, Markowitz LE, Patriarca PA. Vaccination levels and missed opportunities for measles vaccination: a record audit in a public pediatric clinic. Pediatrics 1992;89:589-592.
4. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices and the American Academy of Family Physicians. MMWR Recomm Rep 2002;51(RR-2):1-35.
5. Howson CP, Howe CJ, Fineberg HV, eds. Adverse Effects of Pertussis and Rubella Vaccines. Washington, DC: National Academy Press, last updated 1991. Available at: www.nap.edu/books/0309044995/html/index.html. Accessed on June 10, 2005.
6. Stratton KR, Howe CJ, Johnston RB, eds. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: National Academy Press, Last updated 1994. Available at: www.nap.edu/catalog/2138.html. Accessed on June 10, 2005.
7. Update: vaccine side effects, adverse reactions, contraindications, and precautions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996;45(RR-12):1-35.
8. Tinnion ON, Hanlon M. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2000(2);CD001478.-
9. American Academy of Pediatrics. Active and Passive Immunization. In: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2003;46-49.
1. Wald ER, Dashefsky B, Byers C, Guerra N, Taylor F. Frequency and severity of infections in day care. J Pediatr 1988;112:540-546.
2. Szilagyi PG, Rodewald LE. Missed opportunities for immunizations: a review of the evidence. J Public Health Manag Pract 1996;2:18-25.
3. Farizo KM, Stehr-Green PA, Markowitz LE, Patriarca PA. Vaccination levels and missed opportunities for measles vaccination: a record audit in a public pediatric clinic. Pediatrics 1992;89:589-592.
4. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices and the American Academy of Family Physicians. MMWR Recomm Rep 2002;51(RR-2):1-35.
5. Howson CP, Howe CJ, Fineberg HV, eds. Adverse Effects of Pertussis and Rubella Vaccines. Washington, DC: National Academy Press, last updated 1991. Available at: www.nap.edu/books/0309044995/html/index.html. Accessed on June 10, 2005.
6. Stratton KR, Howe CJ, Johnston RB, eds. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: National Academy Press, Last updated 1994. Available at: www.nap.edu/catalog/2138.html. Accessed on June 10, 2005.
7. Update: vaccine side effects, adverse reactions, contraindications, and precautions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996;45(RR-12):1-35.
8. Tinnion ON, Hanlon M. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2000(2);CD001478.-
9. American Academy of Pediatrics. Active and Passive Immunization. In: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2003;46-49.
Evidence-based answers from the Family Physicians Inquiries Network